Originally published byEU-Startups
GenePlanet, a Ljubljana-based genomics and laboratory platform delivering advanced genetic testing and next-generation sequencing (NGS) services worldwide, has secured a strategic investment from Lauxera Capital Partners, a specialist HealthTech investor. With this investment, the company’s existing investor BlackPeak Capital has partially exited its investment. It, however, retains a meaningful shareholding in the Slovenian company. Niklas […]
The post “Now there is a real chance to become a unicorn”: Slovenia’s GenePlanet secures strategic investment from Lauxera appeared first on EU-Startups.
🌐
More news from European UnionEuropean Union
EUROPE
Related News
Cloud giants pour nearly $600B into capex as AI demand surges
14h ago
As Larry Ellison bets the farm, Oracle says it loves AI-written code, just not in OpenJDK
1d ago
UK government investment arm cops to 40-hour leak of officials' contact details
1d ago
IT boss left root session open for bring-your-kid-to-work day
1d ago
Sci-fi authors Scalzi and Stross decry AI's dystopian impact on their craft
1d ago